The global demand for Point-of-Care Glucose Testing Market is presumed to reach the market size of nearly USD 12.79 BN by 2030 from USD 7.32 BN in 2022 with a CAGR of 7.22% under the study period 2023 - 2030.
Point-of-care glucose testing is a device used to monitor diabetes patients. Point-of-care glucose testing is a valuable tool for managing diabetic patients in an outpatient setting. The instantaneous sharing of test results with healthcare providers is made possible by point-of-care glucose testing equipment and electronic medical records. This device facilitates quick decision-making, decreases turnaround time, and enhances patient care.
The rise in the prevalence of diabetic patients is expected to drive the market growth of point-of-care glucose testing. The changing lifestyle and rise in public awareness are anticipated to scale up the market growth of point-of-care glucose testing. Moreover, the growing government initiative to develop the equipment is expected to support the market of point-of-care glucose testing. The increasing investments in the technological advancement of the product to improve its functionality and accuracy and for the launch of new products are anticipated to boost the market expansion of point-of-care glucose testing. Additionally, the shifting consumer preference from traditional laboratories to new, improved methods to check diabetes levels instantly and conveniently is anticipated to propel the market growth of point-of-care glucose testing. However, sometimes it may provide inaccurate results, hindering the market growth of point-of-care glucose testing.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of point-of-care glucose testing. The growth and trends of point-of-care glucose testing industry provide a holistic approach to this study.
This section of the point-of-care glucose testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By End Use
This section covers the regional outlook, which accentuates current and future demand for the Point-of-Care Glucose Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the point-of-care glucose testing market include F. Hoffmann-La Roche Ltd., Abbott, Nipro, PlatInium Equity Advisors LLC (Lifescan, Inc.), Nova Biomedical, ACON Laboratories, Trividia Health Inc., Prodigy Diabetes Care LLC, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: